HIM
HOOK

Hillhouse Investment Management’s HOOKIPA Pharma HOOK Stock Holding History

Hillhouse Investment Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$4.42M Buy
+65,754
New +$6.98M 0.14% 31

Other funds holding HOOK

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hillhouse Investment Management's HOOK Position: Q2 2019 in Review

Hillhouse Investment Management opened a new position in HOOKIPA Pharma (HOOK) in Q2 2019: 65,754 shares worth $4.42M. The stake represents 0.14% of the portfolio and ranks #31 among its holdings.

33 funds tracked by Wall St. Rank hold HOOK as of Q2 2019.

  • Hillhouse Investment Management held 65,754 shares of HOOKIPA Pharma worth $4.42M as of Q2 2019.
  • HOOKIPA Pharma was a new Hillhouse Investment Management position in Q2 2019.
  • HOOKIPA Pharma made up 0.14% of Hillhouse Investment Management's portfolio in Q2 2019, its #31 holding.
  • 33 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.